As lipid abnormalities cluster within families, an additional aim of this study was to evaluate the familial aggregation of traits associated with this disorder and to estimate the contribution of rare and common genetic variants into LPL and APOA1 genes to the lipid components of AD. The gene discussed is LPL; the disease is Alzheimer disease.